Skip to content

TLX 5841305Recalls & reported problems

Nuvasive, Inc. · TLX Implant, 14x11x31mm 15° · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00887517730015), received between Jul 18, 2017 and Jul 18, 2017 — classified as 1 malfunction.

The most frequently reported specific device problem is “Migration or Expulsion of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Migration or Expulsion of Device1

Patient problems

  • Failure of Implant1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 18, 2017Migration or Expulsion of Device; Migration or Expulsion of Device

    RECEIVED INFORMATION STATING PATIENT UNDERWENT POSTERIOR LATERAL FUSION ON (B)(6) 2017. TWO MONTHS POST-OPERATIVE, RADIOGRAPHS INDICATE THE TRANSFORAMINAL LORDOTIC EXPANDABLE (TLX) IMPLANT MIGRATED POSTERIORLY. PATIENT IS SYMPTOMATIC, REVISION SURGERY HAS NOT BEEN SCHEDULED AT THIS TIME.

    Patient problems: Failure of Implant

    MAUDE report 6721798 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page